The current valuation score of Crinetics Pharmaceuticals Inc is 8.48, ranking 126 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -16.33, which is -71.32% below the recent high of -4.68 and -0.22% above the recent low of -16.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.